CDK4 and esophageal cancer: Some studies have verified that CDK4 is usually overexpressed and/or over-actived in human esophageal cancer [15,16], which can regulate the G1-S phase of the cell cycle by inactivating the tumor-suppressive retinoblastoma protein (Rb) in cancer cells and dividing cells[17].